Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Bihl, Florian ^a   Janssens, Filip ^a   Boehlen, Francoise ^a   Rubbia Brandt, Laura ^a   Hadengue, Antoine ^a   Spahr, Laurent ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; BIOPSY; CASE REPORT; ESOPHAGUS VARICES; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPLASIA; LIVER; LYMPH NODE; PATHOLOGY; PORTAL HYPERTENSION; REMISSION; SPLENOMEGALY;

ABDOMINAL PAIN; ADULT; ASCITES; BIOPSY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HIV INFECTIONS; HUMANS; HYPERPLASIA; HYPERTENSION, PORTAL; LIVER; LYMPH NODES; REMISSION INDUCTION; SPLENOMEGALY;

EID: 77951909387     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-6     Document Type: Article

References (24)

1. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006, 44:7-14. 10.1002/hep.21258, 16799965.
2. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. Aids 2007, 21:187-192. 10.1097/QAD.0b013e3280119e47, 17197809.
3. Garvey LJ, Thomson EC, Lloyd J, Cooke GS, Goldin RD, Main J. Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'. Aids 2007, 21:1494-1495. 10.1097/QAD.0b013e3281e7ed64, 17589202.
4. Arey B, Markov M, Ravi J, Prevette E, Batts K, Nadir A. Nodular regenerative hyperplasia of liver as a consequence of ART. Aids 2007, 21:1066-1068. 10.1097/QAD.0b013e3280fa81cb, 17457112.
5. Sandrine PF, Sylvie A, Andre E, Abdoulaye D, Bernard L, Andre C. Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?. Aids 2007, 21:1498-1499. 10.1097/QAD.0b013e328235a54c, 17589205.
6. Maida I, Garcia-Gasco P, Sotgiu G, Rios MJ, Vispo ME, Martin-Carbonero L, Barreiro P, et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther 2008, 13:103-107.
7. Maida I, Nunez M, Rios MJ, Martin-Carbonero L, Sotgiu G, Toro C, Rivas P, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006, 42:177-182. 10.1097/01.qai.0000221683.44940.62, 16688096.
8. Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, Galambos MR, et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 2008, 6:1167-1169. 10.1016/j.cgh.2008.04.023, 18639498.
9. Tateo M, Sebagh M, Bralet MP, Teicher E, Azoulay D, Mallet V, Pol S, et al. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl 2008, 14:1194-1198. 10.1002/lt.21493, 18668652.
10. Mallet VO, Varthaman A, Lasne D, Viard JP, Gouya H, Borgel D, Lacroix-Desmazes S, et al. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. Aids 2009, 23:1511-1518. 10.1097/QAD.0b013e32832bfa51, 19512859.
11. Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, et al. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009, 104:1707-1714. 10.1038/ajg.2009.165, 19471257.
12. Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009, 49:626-635. 10.1086/603559, 19589079.
13. Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007, 102:2536-2540. 10.1111/j.1572-0241.2007.01428.x, 17640321.
14. Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, Valla D, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002, 51:275-280. 10.1136/gut.51.2.275, 1773310, 12117894.
15. Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 2004, 75:225-230. 10.1002/ajh.20024, 15054815.
16. Gonzalez-Alegre MT, Guerra-Vales JM, Martinez G, Gutierrez A, Guillen V. Nodular regenerative hyperplasia of the liver and Hodgkin's disease: a case report. Acta Gastroenterol Belg 2004, 67:358-360.
17. Dumortier J, Bizollon T, Scoazec JY, Chevallier M, Bancel B, Berger F, Ducerf C, et al. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001, 36:417-422. 10.1080/003655201300051298, 11336168.
18. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005, 11:627-634. discussion 610-621, 10.1002/lt.20431, 15915493.
19. Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schunemann HJ. Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review. J Exp Clin Cancer Res 2008, 27:21. 10.1186/1756-9966-27-21, 2507703, 18634550.
20. Kline ER, Sutliff RL. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med 2008, 56:752-769. 2586126, 18525451.
21. Jacobson MC, Dezube BJ, Aboulafia DM. Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis 2004, 39:1214-1222. 10.1086/424664, 15486847.
22. Recusani F, Di Matteo A, Gambarin F, D'Armini A, Klersy C, Campana C. Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients. Aids 2003, 17(Suppl 1):S88-95.
23. Klein SK, Slim EJ, de Kruif MD, Keller TT, ten Cate H, van Gorp EC, Brandjes DP. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005, 63:129-136.
24. Walker UA, Setzer B, Venhoff N. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. Aids 2002, 16:2165-2173. 10.1097/00002030-200211080-00009, 12409738.